Danaher: Jose-Carlos Gutierrez-Ramos
Danaher has named Jose-Carlos Gutierrez-Ramos as its chief scientific officer and senior VP. He will be an executive officer of the company tasked with defining Danaher's science and technology strategy. He joins Danaher from Abbvie, where he served as head of global drug discovery. Gutierrez-Ramos also previously served as president and CEO of Repertoire Immune Medicines and Synlogic, and prior to that held R&D positions at Pfizer, GlaxoSmithKline, Avidia, and Millennium Pharmaceuticals. He also was a professor at Harvard Medical School in the Department of Genetics and a professor for the Spanish Scientific Research Council.
Biological Dynamics: Kevin Han
Biological Dynamics, a company developing cancer early detection products, has named Kevin Han as CFO. Previously, Han held investor relations, corporate communications, and corporate sustainability strategies at Bio-Rad Laboratories. Prior to that, he was a portfolio manager for Lombard Odier Asset Management. Han started his career at Morgan Stanley and, later, Goldman Sachs, where he covered the medical technology and diagnostics sectors.
Omniome: Kelly Perez
Omniome, a DNA sequencing technology developer, has promoted Kelly Perez to the position of chief operating officer. Perez has been senior vice president of finance and operations at the company since 2017. Prior to Omniome, she was vice president of corporate development and administration at Sequenom, and vice president of finance at Luxtera.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.